Heresco-Levy, U., Ermilov, M., Lichtenberg, P., Bar, G
Ongoing trials (SURPASS T1D) of newer agents such as tirzepatide may also shed additional light on their role in Type 1 diabetes management
As the identified di-, hexa- and decadepsipeptides are not in line with the proposed biosynthetic assembly of three ready-made tetradepsipeptides 8,9 , these findings prompted us to ask whether the candidate depsipeptide esters are released from chemically unstable NRPS-bound PCP- S -ester or TE- O -ester intermediates of cereulide biosynthesis upon transesterification with ethanol, or are formed as artifacts by esterification of free depsipeptides or as cereulide degradation products released upon ethanolysis
When activated, these receptors stimulate insulin secretion in a glucose-dependent manner , meaning insulin is released only when blood glucose levels are elevated, thereby reducing the risk of hypoglycaemia
With repeated dosing, IGF-1 remains elevated above baseline for up to 28 days
Krotkiewski, M
